4,036
Views
16
CrossRef citations to date
0
Altmetric
Research Paper

Data mining-based study of collagen type III alpha 1 (COL3A1) prognostic value and immune exploration in pan-cancer

, ORCID Icon, , , , , , & ORCID Icon show all
Pages 3634-3646 | Received 23 Mar 2021, Accepted 26 May 2021, Published online: 12 Jul 2021

References

  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021 Feb 4;71(3):209–249.
  • Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016 Mar-Apr;66(2):115–132.
  • McGuire S. World cancer report 2014. geneva, switzerland: world health organization, international agency for research on cancer, who press, 2015. Adv Nutr. 2016 Mar 15;7(2):418–419.
  • Siegel RL, Miller KD, Fuchs HE, et al. Cancer Statistics, 2021. CA Cancer J Clin. 2021 Jan;71(1):7–33.
  • Becht E, Giraldo NA, Dieu-Nosjean MC, et al. Cancer immune contexture and immunotherapy. Curr Opin Immunol. 2016Apr;39:7–13.
  • Ho WJ, Jaffee EM, Zheng L. The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities. Nat Rev Clin Oncol. 2020 Sep;17(9):527–540.
  • Wang S, Li Y, Xing C, et al. Tumor microenvironment in chemoresistance, metastasis and immunotherapy of pancreatic cancer. Am J Cancer Res. 2020 Jul 1;10(7):1937–1953.
  • Wu T, Dai Y. Tumor microenvironment and therapeutic response. Cancer Lett. 2017 Feb 28;387: 61–68.
  • Irvine DJ, Dane EL. Enhancing cancer immunotherapy with nanomedicine. Nat Rev Immunol. 2020 May;20(5):321–334.
  • Bonnans C, Chou J, Werb Z. Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol. 2014 Dec;15(12):786–801.
  • Sharma P, Ng C, Jana A, et al. Aligned fibers direct collective cell migration to engineer closing and nonclosing wound gaps. Mol Biol Cell. 2017 Sep 15;28(19):2579–2588.
  • Wang T, Hamilla S, Cam M, et al. Extracellular matrix stiffness and cell contractility control RNA localization to promote cell migration. Nat Commun. 2017 Oct 12;8(1):896.
  • Miller EJ, Epstein EH Jr, Piez KA. Identification of three genetically distinct collagens by cyanogen bromide cleavage of insoluble human skin and cartilage collagen. Biochem Biophys Res Commun. 1971 Mar 19;42(6):1024–1029.
  • Byers PH, Belmont J, Black J, et al. Diagnosis, natural history, and management in vascular Ehlers-Danlos syndrome. Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):40–47.
  • Engqvist H, Parris TZ, Kovács A, et al. Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas. BMC Cancer. 2019 Sep 18;19(1):928.
  • Liu Y, Carson-Walter EB, Cooper A, et al. Vascular gene expression patterns are conserved in primary and metastatic brain tumors. J Neurooncol. 2010 Aug;99(1):13–24.
  • Gonçalves-Ribeiro S, Sanz-Pamplona R, Vidal A, et al. Prediction of pathological response to neoadjuvant treatment in rectal cancer with a two-protein immunohistochemical score derived from stromal gene-profiling. Ann Oncol. 2017 Sep 1;28(9):2160–2168.
  • Tian Y, Ke Y, Ma Y. High expression of stromal signatures correlated with macrophage infiltration, angiogenesis and poor prognosis in glioma microenvironment. PeerJ. 2020 May 20;8: e9038.
  • Shi Y, Zheng C, Jin Y, et al. Reduced expression of METTL3 promotes metastasis of triple-negative breast cancer by m6a methylation-mediated COL3A1 up-Regulation. Front Oncol. 2020;10:1126.
  • Li T, Fan J, Wang B, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017 Nov 1;77(21):e108–e110.
  • Cerami E, Gao J, Dogrusoz U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401–404. Erratum in: Cancer Discov2012 Oct;2(10):960.
  • Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013 Apr 2;6(269): pl1.
  • Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017 Jul;3(45(W1)):W98–W102.
  • Chan TA, Yarchoan M, Jaffee E, et al. Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic. Ann Oncol. 2019 Jan 1;30(1):44–56.
  • Chang L, Chang M, Chang HM, et al. Biomarker for Cancer Immunotherapy. Appl Immunohistochem Mol Morphol. 2018 Feb;26(2):e15–e21.
  • Warde-Farley D, Donaldson SL, Comes O, et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010 Jul;3(suppl_2):W214–20. Web Server issue.
  • Franz M, Rodriguez H, Lopes C, et al. GeneMANIA update 2018. Nucleic Acids Res. 2018 Jul;2(46(W1)):W60–W64.
  • Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545–15550.
  • Angelova M, Charoentong P, Hackl H, et al. Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy. Genome Biol. 2015 Mar 31;16(1):64.
  • Denkert C, von Minckwitz G, Darb-Esfahani S, et al. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy. Lancet Oncol. 2018 Jan;19(1):40–50.
  • Gao Y, Zhou J, Li J. Discoidin domain receptors orchestrate cancer progression: a focus on cancer therapies. Cancer Sci. 2021 Mar;112(3):962–969.
  • Paper W, Kroeber M, Heersink S, et al. Elevated amounts of myocilin in the aqueous humor of transgenic mice cause significant changes in ocular gene expression. Tamm ER Exp Eye Res. 2008 Sep;87(3):257–267.
  • Januchowski R, Świerczewska M, Sterzyńska K, et al. Increased Expression of Several Collagen Genes is Associated with Drug Resistance in Ovarian Cancer Cell Lines. J Cancer. 2016 Jun 25;7(10):1295–1310.
  • Srour MK, Gao B, Dadmanesh F, et al. Gene expression comparison between primary triple-negative breast cancer and paired axillary and sentinel lymph node metastasis. Breast J. 2020 May;26(5):904–910.
  • Chen Y, Pan Y, Ji Y, et al. Network analysis of differentially expressed smoking-associated mRNAs, lncRNAs and miRNAs reveals key regulators in smoking-associated lung cancer. Exp Ther Med. 2018 Dec;16(6):4991–5002.
  • Wang Z, Guo X, Gao L, et al. The immune profile of pituitary adenomas and a novel immune classification for predicting immunotherapy responsiveness. J Clin Endocrinol Metab. 2020 Sep 1;105(9):e3207–23.
  • Kikuchi T, Mimura K, Ashizawa M, et al. Characterization of tumor-infiltrating immune cells in relation to microbiota in colorectal cancers. Cancer Immunol Immunother. 2020 Jan;69(1):23–32.
  • Giraldo NA, Becht E, Pagès F, et al. Orchestration and prognostic significance of immune checkpoints in the microenvironment of primary and metastatic renal cell cancer. Clin Cancer Res. 2015 Jul 1;21(13):3031–3040.
  • Cohen R, Hain E, Buhard O, et al. Association of primary resistance to immune checkpoint inhibitors in metastatic colorectal cancer with misdiagnosis of microsatellite instability or mismatch repair deficiency status. JAMA Oncol. 2019 Apr 1;5(4):551–555.
  • Chen Z, Soutto M, Rahman B, et al. Integrated expression analysis identifies transcription networks in mouse and human gastric neoplasia. Genes Chromosomes Cancer. 2017 Jul;56(7):535–547.
  • Zhao X, Guan JL. Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis. Adv Drug Deliv Rev. 2011 Jul 18;63(8):610–615.
  • Yeh MH, Tzeng YJ, Fu TY, et al. Extracellular matrix-receptor interaction signaling genes associated with inferior breast cancer survival. Anticancer Res. 2018 Aug;38(8):4593–4605.
  • Eke I, Cordes N. Focal adhesion signaling and therapy resistance in cancer. Semin Cancer Biol. 2015 Apr;(31):65–75. DOI:10.1016/j.semcancer.2014.07.009.
  • Ambrogio C, Gómez-López G, Falcone M, et al. Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma. Nat Med. 2016 Mar;22(3):270–277.
  • Xie X, He H, Zhang N, et al. Overexpression of DDR1 promotes migration, invasion, though EMT-related molecule expression and COL4A1/DDR1/MMP-2 signaling axis. Technol Cancer Res Treat. 2020Jan-Dec;19:1533033820973277.